دورية أكاديمية
Isolated limb perfusion with melphalan for melanoma.
العنوان: | Isolated limb perfusion with melphalan for melanoma. |
---|---|
المؤلفون: | Nieweg OE; Melanoma Institute Australia, North Sydney, NSW, Australia., Kroon BB |
المصدر: | Journal of surgical oncology [J Surg Oncol] 2014 Mar; Vol. 109 (4), pp. 332-7. Date of Electronic Publication: 2014 Jan 14. |
نوع المنشور: | Journal Article; Review |
اللغة: | English |
بيانات الدورية: | Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0222643 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-9098 (Electronic) Linking ISSN: 00224790 NLM ISO Abbreviation: J Surg Oncol Subsets: MEDLINE |
أسماء مطبوعة: | Publication: <2005-> : Hoboken, NJ : Wiley-Liss Original Publication: New York, Plenum. |
مواضيع طبية MeSH: | Antineoplastic Agents, Alkylating/*administration & dosage , Chemotherapy, Cancer, Regional Perfusion/*methods , Melanoma/*drug therapy , Melphalan/*administration & dosage, Humans ; Melanoma/blood supply ; Melanoma/pathology ; Melanoma/surgery ; Randomized Controlled Trials as Topic |
مستخلص: | Isolated limb perfusion with melphalan is a well-established and effective treatment for inoperable melanoma metastases of the extremities, with an overall response rate of 80% and a complete response rate of 54%. The surgical technique is complex and serious morbidity can occur, but with attention to detail major side effects can be kept to a minimum. This article reviews the technique, results and other aspects of this sophisticated form of treatment. (© 2014 Wiley Periodicals, Inc.) |
فهرسة مساهمة: | Keywords: limb perfusion; metastases; regional chemotherapy; review |
المشرفين على المادة: | 0 (Antineoplastic Agents, Alkylating) Q41OR9510P (Melphalan) |
تواريخ الأحداث: | Date Created: 20140115 Date Completed: 20140403 Latest Revision: 20220408 |
رمز التحديث: | 20221213 |
DOI: | 10.1002/jso.23558 |
PMID: | 24421252 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1096-9098 |
---|---|
DOI: | 10.1002/jso.23558 |